Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 26, 2023 08:00 ET | Source: Myriad Genetics, Inc.

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

Partnership covers development of lab-developed and distributable kit-based companion diagnostic testsCombined strengths in assay development, clinical testing, and regulatory approvals offers pharma...
September 28, 2023 07:00 ET | Source: Myriad Genetics, Inc.

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results from a nationwide survey...
September 19, 2023 09:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic...
September 19, 2023 07:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Issues 2022 Environmental, Social and Governance Report

SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its second annual Environmental, Social...
September 18, 2023 08:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer

SALT LAKE CITY, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with Memorial Sloan...
September 06, 2023 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work

SALT LAKE CITY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Great Place To Work® and Fortune magazine...
September 06, 2023 07:00 ET | Source: Myriad Genetics, Inc.

New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women

SALT LAKE CITY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today revealed new nationwide survey results indicating...
September 05, 2023 08:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference

SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced management will participate in the...
August 22, 2023 09:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of...
August 17, 2023 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Host Investor Day on September 19, 2023

SALT LAKE CITY, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will host an Investor Day at the newly constructed Dr....

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right